David A. Siegel Aspira Women'S Health Inc. Transaction History

Two Sigma Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $28,160 - $76,736	-70,400 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $107,008 - $220,096	-121,600 Reduced 63.33%	70,400 $73,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $245,640 - $516,901	150,700 Added 364.89%	192,000 $340,000
Q3 2021 Nov 15, 2021	BUY	$3.19 - $5.48 $131,747 - $226,324	41,300 New	41,300 $134,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.